These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 26583088)

  • 1. Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs.
    Molinaro M; Ameri P; Marone G; Petretta M; Abete P; Di Lisa F; De Placido S; Bonaduce D; Tocchetti CG
    Biomed Res Int; 2015; 2015():138148. PubMed ID: 26583088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced cardiomyopathy.
    Yusuf SW; Ilias-Khan NA; Durand JB
    Expert Rev Cardiovasc Ther; 2011 Feb; 9(2):231-43. PubMed ID: 21506294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac toxicity of anticancer agents.
    Colombo A; Cipolla C; Beggiato M; Cardinale D
    Curr Cardiol Rep; 2013 May; 15(5):362. PubMed ID: 23512625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging issue of cardiac dysfunction induced by antineoplastic angiogenesis inhibitors.
    Tocchetti CG; Gallucci G; Coppola C; Piscopo G; Cipresso C; Maurea C; Giudice A; Iaffaioli RV; Arra C; Maurea N
    Eur J Heart Fail; 2013 May; 15(5):482-9. PubMed ID: 23325019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concepts in cardio-oncology: definitions, mechanisms, diagnosis and treatment strategies of cancer therapy-induced cardiotoxicity.
    Wickramasinghe CD; Nguyen KL; Watson KE; Vorobiof G; Yang EH
    Future Oncol; 2016 Mar; 12(6):855-70. PubMed ID: 26829050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiotoxicity of Biological Therapies in Cancer Patients: An In-depth Review.
    Madanat L; Gupta R; Weber P; Kumar N; Chandra R; Ahaneku H; Bansal Y; Anderson J; Bilolikar A; Jaiyesimi I
    Curr Cardiol Rev; 2023; 19(3):e310522205428. PubMed ID: 35642110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left Ventricular Dysfunction and Chemotherapeutic Agents.
    Clasen SC; Wald JW
    Curr Cardiol Rep; 2018 Mar; 20(4):20. PubMed ID: 29520629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors.
    Maurea N; Coppola C; Piscopo G; Galletta F; Riccio G; Esposito E; De Lorenzo C; De Laurentiis M; Spallarossa P; Mercuro G
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e19-e26. PubMed ID: 27755239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using cardiac biomarkers and treating cardiotoxicity in cancer.
    Colombo A; Cardinale D
    Future Cardiol; 2013 Jan; 9(1):105-18. PubMed ID: 23259478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiotoxicity.
    Brana I; Tabernero J
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii173-9. PubMed ID: 20943611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy-induced cardiotoxicity: Incidence, diagnosis and prevention].
    Nelson-Veniard M; Thambo JB
    Bull Cancer; 2015; 102(7-8):622-6. PubMed ID: 25935231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newest echocardiographic techniques for the detection of cardiotoxicity and heart failure during chemotherapy.
    Sawaya H; Plana JC; Scherrer-Crosbie M
    Heart Fail Clin; 2011 Jul; 7(3):313-21. PubMed ID: 21749883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular toxicities of cancer chemotherapy.
    Bonita R; Pradhan R
    Semin Oncol; 2013 Apr; 40(2):156-67. PubMed ID: 23540741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiotoxicity of cancer therapy].
    Marek J; Linhart A; Rucklová Z; Haber J; Korínek J
    Vnitr Lek; 2011 May; 57(5):472-84. PubMed ID: 21695928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of QT prolongation induced by anti-cancer drugs: Target therapy and old agents. Different algorithms for different drugs.
    Coppola C; Rienzo A; Piscopo G; Barbieri A; Arra C; Maurea N
    Cancer Treat Rev; 2018 Feb; 63():135-143. PubMed ID: 29304463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Imaging: Multimodality Advances and Surveillance Strategies in Detection of Cardiotoxicity.
    Moonen M; Oury C; Lancellotti P
    Curr Oncol Rep; 2017 Aug; 19(10):63. PubMed ID: 28791609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).
    Pituskin E; Haykowsky M; McNeely M; Mackey J; Chua N; Paterson I
    BMC Cancer; 2016 Sep; 16(1):733. PubMed ID: 27629548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deformation Analysis of Myocardial Layers Detects Early Cardiac Dysfunction after Chemotherapy in Bone Marrow Transplantation Patients: A Continuous and Additive Cardiotoxicity Process.
    Paraskevaidis IA; Makavos G; Tsirigotis P; Psarogiannakopoulos P; Parissis J; Gkirkas K; Pessach I; Ikonomidis I
    J Am Soc Echocardiogr; 2017 Nov; 30(11):1091-1102. PubMed ID: 28864152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.
    Albini A; Pennesi G; Donatelli F; Cammarota R; De Flora S; Noonan DM
    J Natl Cancer Inst; 2010 Jan; 102(1):14-25. PubMed ID: 20007921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for cardiac dysfunction in anthracycline-exposed childhood cancer survivors.
    Armenian SH; Gelehrter SK; Vase T; Venkatramani R; Landier W; Wilson KD; Herrera C; Reichman L; Menteer JD; Mascarenhas L; Freyer DR; Venkataraman K; Bhatia S
    Clin Cancer Res; 2014 Dec; 20(24):6314-23. PubMed ID: 24947931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.